Table 2.
The participants and outcome of included study.
| Study | randomised participants | drop-out | cross-over | actually received pain relief | intenstion-to-treat | Intrapartum fever definition | temperature mode | measure duration |
|---|---|---|---|---|---|---|---|---|
| Logtenberg 2017 [15] | 418 |
RPCA:98 EA:105 |
RPCA:11 EA:14 |
RPCA:94 EA:76 |
yes | > 38 °C | not reported | during analgesia |
| Freeman 2015 [14] | 1414 |
RPCA:22 EA:31 |
RPCA:53 EA:33 |
RPCA:447 EA:347 |
yes | > 38 °C | not reported | during labor |
| Douma 2015 [16] | 116 |
RPCA:8 EA:1 |
no | ≥38 °C | tympanic membrance | within 4 h | ||
| Stocki 2014 [17] | 40 |
RPCA:1 EA:0 |
RPCA:3 EA:1 |
RPCA:19 EA:20 |
no | not reported | not reported | within 1 h |
| Ismail 2012 [21] | 1140 |
RPCA:0 EA:0 |
not report |
RPCA:380 EA:380 CSEA:380 |
no | not reported | oral temperature | within 1 h |
| Evron 2008 [20] | 213 | 12 | not report | 201 | no | ≥38 °C | oral temperature | within 6 h |
RPCA remifentanil patient-controlled analgesia, EA epidural analgesia, CSEA combined spinal with epidural analgesia, Con control, CI continuous infusion.